Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

PharmiWeb

ABPI London offices

Biosimilars should be routinuely assessed by NICE, says ABPI

Calls for biosimilars to go through full HTA process

- PMLiVE

Teva plans revamp as 2013 revenues expected to fall short

Expects increased competition for biggest-selling drug Copaxone

- PMLiVE

Pharma R&D costs up tenfold since 1970s

Average cost to bring a drug to market now $1.9bn, according to the Office for Health Economics

- PMLiVE

Gorsky named chairman of J&J

Completes transition from former CEO and chair Bell Weldon

- PMLiVE

Genzyme makes Brendan Martin UK and Ireland manager

Replaces Paul Drohan who returns to Canada

- PMLiVE

FDA approves Exelixis’ Cometriq for rare thyroid cancer

Genomics-based discovery company also submits the drug to EU regulators

- PMLiVE

RSA appoints Michael Huberts as executive search consultant

He joins from Tokyo-based executive search firm Optia Partners

- PMLiVE

Talent management: Taking the blinkers off

The struggle to find talented staff shows no sign of abating but there are steps that can and should be taken to alleviate the problem

- PMLiVE

Sanofi takes anti-counterfeiting message to the skies

Hopes to reach four million passengers with Air France film

- PMLiVE

Streaming Well and Terrence Higgins Trust launch HIV education series

Online videos target young people in Britain

- PMLiVE

Efforts to curb HIV must be stepped up, says report

HIV/AIDS advocacy group ONE pushes for more funding to end epidemic

- PMLiVE

Merck withdraws filing for sarcoma drug in Europe

Oncology setback sees ridaforolimus licence application pulled

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links